TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Initial post-treatment healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Prostate Score Symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skill and Knowledge of BSE
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Attitude of Web-Based Education
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-Directed Learning Skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Itch related to Haemorrhoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of nerd neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of radiation dermatitis grade 2-3 wound size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Prediction accuracy index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of BoP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of treatment emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of treatment emergent serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Urinary Isothiocyanates Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Willingness to Work with Elderly People
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Menstrual blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal Learning Test (VLT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline in Disability of Arm, Shoulder and Hand Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Standardized Swallowing Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change of modified Rankin score at 16 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Number of treatment-emergent adverse events and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Achieving SRI-4 Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of diabetic patients without diabetic foot ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of patients with diabetic foot ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of patients receiving diabetic foot care education
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Low Density Lipoprotein (LDL) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in fasting glucose value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Effect of the synbiotic in pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inflammatory marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Questionnaire to assess quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Dose Deviation Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 3 or Higher Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical and Functional Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in appearance of periorbital puffiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in appearance of dark circles underneath eyes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in participants' perception of the appearance of periorbital puffiness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in participants' perception of the appearance of dark circles underneath eyes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: microvascular endothelial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: microvascular endothelin-1-mediated constriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Temporomandibular Dysfunction Disability Index (TDI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Maximum Tolerated Light Dose (MTD)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of white blood cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Blood cells count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Lipid profile identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of CR/CRi after first induction therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of CR/CRi after second induction therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep quality and patterns
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Melatonin Prescription Status
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Histopathological properties of suspected breast cancer tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Success rate of obturator nerve block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: metabolic parameters of primary lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of symptomatic outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients without any adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Observed Drug Concentration (Cmax) of Metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of laryngeal disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in HOA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of case load identified as requiring a palliative care approach
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pain and discomfort on VAS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence and severity of postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Malignant end point events
Endpoint domain: Mortality/survival
Primary endpoint: Circulating levels of L-arginine metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Markers of endothelial inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Production of reactive oxygen species (ROS) in endothelial cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epigenetic and transcriptomic patterns in endothelial cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of malnutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average Number of Days Covered (PDC)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants with a Medication Health Center visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Age at maternity discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in VO2max between Cycle ergometer and treadmill
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent change in the level of circulating central memory T cells (TCM) after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adherent Scalp Flaking Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Scalp Condition using Phototrichogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Quality of life on apixaban and aspirin
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Gastrointestinal dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Type of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neural sensitization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Receiving a Pap Test
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Intention to Receive a Pap Test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline in absolute number of CD19+/CD5+ CLL cells at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from baseline in cardiorespiratory fitness (CRF: VO2peak) at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in intention to use cannabis in the future
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Basal Pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Residual Pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Wave Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Histopathologic Inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: rates of overdose
Endpoint domain: Mortality/survival
Primary endpoint: SOFA score variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between PID RDT and referent test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smartphone Addiction Scale-Short version (SAS-SV)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patient Health Questionnaire (PHQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of Dose Limiting Toxicities of ARV-766
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients with Adverse Events as a measure of safety and tolerability of ARV-766
Endpoint domain: Adverse events/effects
Primary endpoint: To evaluate the clinical anti-tumor activity of ARV-766 in patients with mCRPC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Plasmatic level of arachidonic acid and eicosapentaenoic acid (AA:EPA) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Main compositional changes in gut microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with freedom from CTCAE Grade 3 or greater
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose (MTD) in patients with dilated cardiomyopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change from baseline pain level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preterm pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mother's anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: circulating tumor cell
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: T cell marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Submaximal Exercise Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in revised Venous Clinical Severity Score (rVCSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Villalta Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in EuroQol-5 Dimension (EQ-5D) Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maximum breath-hold time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presenting rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Score obtained in outcome assessment simulation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Tumour recurrence or metastasis
Endpoint domain: Mortality/survival
Primary endpoint: Pain tolerance (time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor effects of drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in strip meniscometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance (% agreement) between size selection methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SARS-CoV-2 seropositivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasound Shoulder Pathology Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of ultrasound use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Box and Block test (BBT) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of screen to treatment within 3 months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Constant Murley Score (CMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device Related or Procedure Related Adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Missed scanning rate of adjacent important anatomical structures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ODI (Oswestry Disability Index) change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Predictive performance of the COPD frequent seizure risk prediction model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in eczema severity and symptoms (EASI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Improvement in eczema severity and symptoms (SCORAD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Oral Disease Severity Scale (ODSS) Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Euclidean distance between target and actual point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in person-centered maternity care (PCMC) score from baseline to 6 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in person-centered maternity care (PCMC) score from 6 months sustained at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in person-centered maternity care (PCMC) score from baseline to 12 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of patients with viral neutralization capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: FACIT fatigue scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: sC5b-9 release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: s100beta release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Patient threshold value for need for future surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: changes in pain EVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in pain pressure algometers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: language assessment performance score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Long-term weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Functional outcome by DASH score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Functional outcome by Purdue Pegboard Test
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Functional outcome by Michigan Hand Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percent patients within target BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total consumption of rescue analgesics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pain score assessed by numerical pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPID on the visual analog score VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral Hygiene Status assessed by Oral Hygiene Index Simplified (OHI-S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral Hygiene Status assessed by Gingival Index (GI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of extreme preterm birth
Endpoint domain: Mortality/survival
Primary endpoint: Very Good Partial Response (VGPR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse events (AE) after infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Change in postprandial insulin responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Whole-mouth Mean Plaque Index (TPI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anxiety and depression difference
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: fertility stress difference
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: post-traumatic stress responses difference
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perception Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gestational week of delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Defined Daily Dose (DDD)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Increase in pulmonary functional capillary surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of new-onset postoperative atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pelvic Floor Muscle Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pelvic Floor Dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dysfunctional Voiding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Safety and toleration
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Urticaria Activity Score Over 7 Days (UAS7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of incisional hernia recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Muscle Stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: The Tampa Scale for Kinesiophobia (TSK)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in total score of Perceived Deficits Questionnaire-Depression
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of severe adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline perceived pain at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline Leisure Time Physical Activity Instrument (LTPAI) at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from baseline Widespread Pain Index (WPI) at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Dengue (DENV) Viral Load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Hemoglobin A1C level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Foot self-care adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of geriatric oral hygiene scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Attitudes of geriatric oral hygiene scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing